Eye Inflammation
Showing 1 - 25 of >10,000
Antioxidant Activity on Postoperative Inflammation in Patients
Recruiting
- Cataract
- Myopia
- Cataract surgery, Femtosecond-LASIK, SMILE
-
Taoyuan, Taoyuan City, Taiwan
- +1 more
Jun 6, 2023
Dry Eye Syndrome, Healthy Control, Sjögren's Syndrome and Other
Not yet recruiting
- Dry Eye Syndrome
- +3 more
- Whole-genome genotyping
- +11 more
-
Taipei, Taiwan (r.o.c.), TaiwanChing-Mao Chang
Aug 9, 2022
Biomarkers in Ocular Inflammation and Uveitis
Enrolling by invitation
- Uveitis
- Ocular Inflammation
-
Bethesda, MarylandNational Eye Institute (NEI)
Aug 24, 2022
Dry Eye, Keratoconjunctivitis Sicca, Ocular Inflammation Trial in Mexico City (punctum plug insertion, Eye Drops, Lubricant)
Recruiting
- Dry Eye
- +2 more
- punctum plug insertion
- Eye Drops, Lubricant
-
Mexico City, Coyoacán, MexicoAsociación para Evitar la Ceguera en México (APEC)
Nov 9, 2022
Cataract Trial in United States (Clobetasol Propionate, Vehicle)
Inflammation Eye, Pain, Postoperative, Cataract Trial in United States (Dexamethasone Ophthalmic Suspension, Vehicle of OCS-01)
Not yet recruiting
- Inflammation Eye
- +2 more
- Dexamethasone Ophthalmic Suspension
- Vehicle of OCS-01
-
Inglewood, California
- +11 more
Nov 7, 2023
Cataract Trial in United States (Clobetasol propionate, Vehicle)
Anterior Chamber Inflammation by Optical Coherence Tomography
Recruiting
- Uveitis
-
Cleveland, OhioCole Eye Institute
Apr 27, 2022
Post Surgical Ocular Inflammation Trial in United States (TRS01 eye drops, Placebo eye drops)
Completed
- Post Surgical Ocular Inflammation
- TRS01 eye drops
- Placebo eye drops
-
Inglewood, California
- +4 more
Oct 13, 2021
Dry Eye Disease Trial in Lucca (Artificial tear MDI - 101)
Completed
- Dry Eye Disease
- Artificial tear MDI - 101
-
Lucca, ItalyOphthalmology unit
Dec 1, 2021
Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome
Recruiting
- Autoimmunity
- Dry Eye Syndrome
- Cross-sectional study
-
Singapore, SingaporeCynthia Boo
Mar 22, 2022
Ocular Inflammation and Pain Trial in Puerto Rico, United States (APP13007, 0.05%, Matching Vehicle Placebo for APP13007, 0.05%)
Completed
- Ocular Inflammation and Pain
- APP13007, 0.05%
- Matching Vehicle Placebo for APP13007, 0.05%
-
Scottsdale, Arizona
- +35 more
Jul 25, 2022
Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in Plano (Yutiq 0.18 MG Drug Implant, Sham Injection)
Not yet recruiting
- Uveitis
- +3 more
- Yutiq 0.18 MG Drug Implant
- Sham Injection
-
Plano, TexasTexas Retina Associates
Aug 3, 2022
Cataract, Ocular Inflammation, Ocular Hypertension Trial (Intraoperative delivery of medication, Kenalog (Triamcinolone),
Not yet recruiting
- Cataract
- +3 more
- Intraoperative delivery of medication, Kenalog (Triamcinolone)
- Topical post-operative eyedrops, Prednisolone acetate
- (no location specified)
Aug 4, 2022
Ocular Surface Disease, Ocular Inflammation Trial in Rome (CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion, cationorm eye
Active, not recruiting
- Ocular Surface Disease
- Ocular Inflammation
- CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion
- cationorm eye drops
-
Rome, ItalyUniversity Campus Bio Medico
Jan 5, 2022
Rheumatoid Arthritis Trial in Enschede (EMDR)
Not yet recruiting
- Rheumatoid Arthritis
- EMDR
-
Enschede, Overijssel, NetherlandsMedisch Spectrum Twente
Jul 4, 2023
Intraocular Pressure, Neovascular Glaucoma, Vascular Endothelial Growth Factor Overexpression Trial in Bangkoknoi (Aflibercept
Completed
- Intraocular Pressure
- +3 more
- Aflibercept Ophthalmic
-
Bangkoknoi, Bangkok, ThailandNaris Kitnarong
Jul 11, 2021
Disorders of the Eye Following Cataract Surgery Trial in Houston (Dexamethasone, Vehicle Placebo)
Not yet recruiting
- Disorders of the Eye Following Cataract Surgery
- Dexamethasone
- Vehicle Placebo
-
Houston, TexasOculis Investigative Site
Apr 28, 2022
Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain Trial in Cleveland (Dexamethasone Ophthalmic Insert,
Enrolling by invitation
- Vitreoretinal Surgery
- +3 more
- Dexamethasone Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
Feb 24, 2022
Ocular Inflammation and Pain After Cataract Surgery Trial in United States (APP13007, 0.05%, Matching Vehicle Placebo for
Recruiting
- Ocular Inflammation and Pain After Cataract Surgery
- APP13007, 0.05%
- Matching Vehicle Placebo for APP13007, 0.05%
-
Mesa, Arizona
- +31 more
Mar 15, 2022
Post-surgical Ocular Inflammation, Post-surgical Ocular Pain Trial in United States (SURF-201, Placebo)
Completed
- Post-surgical Ocular Inflammation
- Post-surgical Ocular Pain
- SURF-201
- Placebo
-
Hemet, California
- +9 more
Oct 15, 2021
Dry Eye Trial in Wilkes-Barre (Lifitegrast 5% Ophthalmic Solution)
Enrolling by invitation
- Dry Eye
- Lifitegrast 5% Ophthalmic Solution
-
Wilkes-Barre, PennsylvaniaBucci Laser Vision
Sep 28, 2021
Pterygium of Both Eyes Trial in Brandon (Intracanalicular Dexamethasone, (0.4 mg) Insert, Prednisolone Acetate)
Active, not recruiting
- Pterygium of Both Eyes
- Intracanalicular Dexamethasone, (0.4 mg) Insert
- Prednisolone Acetate
-
Brandon, FloridaBrandon Eye Associates
Jul 19, 2022
Entropion, Inflammation in the Eyelid Trial in London (suture)
Suspended
- Entropion
- Inflammation in the Eyelid
- suture
-
London, United KingdomWestern Eye Hospital
Nov 18, 2021
Glaucoma Following Surgery Trial in Memphis (DEXTENZA, Topical Dexamethasone)
Not yet recruiting
- Glaucoma Following Surgery
- DEXTENZA
- Topical Dexamethasone
-
Memphis, TennesseeHamilton Eye Institute
Nov 9, 2021